Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

During the TACCSTER 2025 poster session, Texas researchers highlight the methods, results, and insights of their work, ...

While 90% of breast cancer patients in rich countries survive five years, rates drop to as low as 40% in some low-resource nations due to late detection and delayed treatment.

Some colorful lizards and a mathematical formula from the finance sector have been used to build a new framework to model ...

Missouri’s cattle industry is experiencing historic highs. Discover how the Show-Me Select Replacement Heifer Program is ...

The FDA has approved Seattle Genetics' breast cancer drug Tukysa (tucatinib) four months early, including in certain patients whose disease has spread to the brain. Tukysa has been approved in ...

There are a lot of tutorials to get through early in Dying Light: The Beast. Many of them are helpful as you learn the ins and outs of the mechanics, but after a few hours, they can become an ...

Roche and Merck & Co have got their respective immunotherapies Tecentriq and Keytruda approved in bladder cancer – but the problem of low response rates remains. At the ASCO annual conference in ...

Prostate cancer advancements highlight genetic mutations' impact on therapy and family health, emphasizing early treatment strategies for better outcomes. In recognition of September as Prostate ...

Abstract: Threats that have been primarily targeting nation states and their associated entities have expanded the target zone to include the private and corporate sectors. This class of threats, well ...

The Foodsmart program is changing how people think about food by using smart tech to make nutrition a lot more personal and practical. These tools don’t just help people track what they eat—they ...